Concepedia

Effects of glucagon-like peptide-1 receptor agonists on gastric mucosal visibility and retained gastric contents during EGD

Malcolm Chapman, Dalton A. Norwood, Christopher Price, Basma Abdulhadi, Kondal R. Kyanam Kabir Baig, Ali M. Ahmed, Shajan Peter, Justin S. Routman, Sergio A. Sánchez‐Luna, Elizabeth W. Duggan,

Gastrointestinal Endoscopy · 2024 · 32 citations · 8 references

DOI

Concepts

References

8

Tirzepatide Once Weekly for the Treatment of Obesity

Ania M. Jastreboff, Louis J. Aronne, Nadia N. Ahmad et al. · New England Journal of Medicine · 2022 · 3.2K citations · Full text

, , +15

Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults

J van Can, Birgitte Sloth, Camilla Bjørn Jensen et al. · International Journal of Obesity · 2013 · 518 citations · Full text

, , +17

Association of <scp>glucagon‐like peptide</scp>‐1 receptor agonist treatment with gastric residue in an esophagogastroduodenoscopy

Toshiko Kobori, Yukiko Onishi, Yoko Yoshida et al. · Journal of Diabetes Investigation · 2023 · 139 citations · Full text

, , +17

AGA Rapid Clinical Practice Update on the Management of Patients Taking GLP-1 Receptor Agonists Prior to Endoscopy: Communication

Jana G. Hashash, Christopher C. Thompson, Andrew Y. Wang · Clinical Gastroenterology and Hepatology · 2023 · 127 citations

, , +13

Influence of semaglutide use on the presence of residual gastric solids on gastric ultrasound: a prospective observational study in volunteers without obesity recently started on semaglutide

Marc Sherwin, Joshua Hamburger, Daniel Katz et al. · Canadian Journal of Anesthesia/Journal canadien d anesthésie · 2023 · 115 citations · Full text

, , +13